US Codex
C.F.R.
Browse by date
Notes

§866.5760. Tryptase test system.

21 C.F.R. § 866.5760

(a)
Identification. A tryptase test system is a device that aids in the diagnosis of systemic mastocytosis. It is intended for in vitro diagnostic use as an aid in the clinical diagnosis of patients with a suspicion of systemic mastocytosis in conjunction with other clinical and laboratory findings.
(b)
Classification. Class II (special controls). The special control is FDA's guideline entitled “Class II Special Controls Guideline: Tryptase Test System as an Aid in the Diagnosis of Systemic Mastocytosis.” For availability of the document, see § 866.1(e).
Notes, amendments, and revision history

Amendments

[79 FR 56010, Sept. 18, 2014]

Authority

Authority: 21 U.S.C. 351, 360, 360c, 360e, 360j, 360 l, 371.

Source

Source: 47 FR 50823, Nov. 9, 1982, unless otherwise noted.

Amendments

[79 FR 56010, Sept. 18, 2014]